Results 131 to 140 of about 9,356 (215)

Proteomic Characterization Reveals CYP2S1 as a Mediator of Drug Resistance in PDAC. [PDF]

Pancreas
Thiel V, Nadler WM, Kerner A, Kuhlmann L, Reitberger M, Vorberg T, Schwerd-Kleine P, Noll E, Giese NA, Yen HY, Steiger K, Vogel V, Klein C, Hackert T, Koschny R, Opitz CA, Trumpp A, Sprick MR, Rösli C.   +18 more
europepmc   +1 more source

Introduction to animal modelling: factors and tools for choosing the optimal model for sarcoma research-a comprehensive literature review. [PDF]

Transl Cancer Res
Remiszewski P, Remiszewski P, Czarnecka AM, Siedlecki E, Mikula M, Rutkowski P.   +5 more
europepmc   +1 more source

The role of the aryl hydrocarbon receptor in ovarian development, function, xenobiotic metabolism, and disease†. [PDF]

Biol Reprod
Dean AE, Flaws JA.
europepmc   +1 more source

Non-Genotoxic and Environmentally Relevant Lower Molecular Weight Polycyclic Aromatic Hydrocarbons Significantly Increase Tumorigenicity of Benzo[<i>a</i>]pyrene in a Lung Two-Stage Mouse Model. [PDF]

Toxics
Bauer AK, Romo D, Friday F, Cho K, Velmurugan K, Upham BL.   +5 more
europepmc   +1 more source

Supranutritional Selenomethionine but not Selenite Reduces Malignant Cell Transformation. [PDF]

Biol Trace Elem Res
Meyer CE, Schwarz M, Meyer FB, Thierbach R, Kipp AP.   +4 more
europepmc   +1 more source

A collagen hydrogel-based 3D Heparg model for enhanced hepatocyte function and assessment of cholestatic drug-induced liver injury. [PDF]

Arch Toxicol
Timor-López E, Tolosa L, Donato MT.
europepmc   +1 more source

Disruption of CD91 association with AXL and Fgr abrogates HSP-mediated signaling and cancer immunosurveillance. [PDF]

Oncoimmunology
Harkness T, Sedlacek AL, Shah K, Juergens AM, Greenberger J, Mukherjee A, Binder RJ.   +6 more
europepmc   +1 more source

The Pharmacological Evidences for the Involvement of AhR and GPR35 Receptors in Kynurenic Acid-Mediated Cytokine and Chemokine Secretion by THP-1-Derived Macrophages. [PDF]

Molecules
Sawa-Wejksza K, Parada-Turska J, Turski W.   +2 more
europepmc   +1 more source

Potent lung tumor promotion by inhaled MWCNT. [PDF]

Nanotoxicology
Porter DW, Orandle MS, Hubbs A, Staska LM, Lowry D, Kashon M, Wolfarth MG, McKinney W, Sargent LM.   +8 more
europepmc   +1 more source

Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential. [PDF]

Pharmacol Rev
Bobrovs R, Olafsen NE, Åhrling SS, Matthews J.   +3 more
europepmc   +1 more source